- Landmark Study Shows Antibody Therapy Controls 92% of Severe Asthma Cases ScienceAlert
- Biologic therapy shown to reduce steroid use in 92% of severe asthmatics New Atlas
- Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study The Lancet
- New Asthma Treatment Offers Hope With Reduced Steroid Dependence NDTV
- Major asthma breakthrough as ‘revolutionary’ jab could end the need for inhalers, study suggests… The Sun
Read More: Landmark Study Shows Antibody Therapy Controls 92% of Severe Asthma Cases –